GAVRETO 100mg capsules EGIS
Active substance: pralsetinib
Indicated for: lung cancer; thyroid cancer
Find medicines for human use by name or active substance.
Browse by initial
101–120 of 564 medicines
Active substance: pralsetinib
Indicated for: lung cancer; thyroid cancer
Active substance: obinutuzumab
Indicated for: hematologic malignancies
Active substance: sildenafil
Indicated for: erectile dysfunction; pulmonary arterial hypertension
Active substance: sildenafil
Indicated for: erectile dysfunction; pulmonary arterial hypertension
Active substance: sildenafil
Indicated for: erectile dysfunction; pulmonary arterial hypertension
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gefitinib
Indicated for: non-small cell lung cancer
Active substance: gelatine
Indicated for: hypovolemia; plasma volume expansion
Active substance: timolol
S01ED01 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; hypertension
Active substance: timolol
S01ED01 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; hypertension
Active substance: gelatine
Indicated for: hypovolemia; plasma volume expansion
Active substance: gelatine
Indicated for: hypovolemia; plasma volume expansion
Active substance: timolol
S01ED01 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; hypertension
Active substance: gemcitabine
L01BC05 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: gemcitabine
L01BC05 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.